Kami J. Maddocks, MD, Provides Insight Into the Biggest Breakthroughs in Lymphoma Thus Far in 2022
September 1st 2022Kami J. Maddocks, MD, talks CAR T-cell therapy approvals for the treatment of relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma plus a new treatment supplanting R-CHOP.